The news is directly related to Lazard and is likely to influence investor sentiment. While the Overweight rating suggests that Morgan Stanley expects the stock to outperform, the lowering of the price target may create some uncertainty. However, as the price target is still above the current market price, the overall impact is expected to be neutral.